News Briefs

December 2009
American Journal of Health-System Pharmacy;12/15/2009, Vol. 66 Issue 24, p2161
Academic Journal
The article offers news briefs related to business activities. The website ResearchMatch.org was launched by a national network of medical research groups with the help of a federal fund on November 10, 2009 to provide research studies to enhance the health and well-being of the people. The company Merck is the combination of Merck and Co. Inc. and Schering-Plough Corp. on November 3, 2009. Meanwhile, the main office of Wyeth in Collegeville was acquired by Pfizer Inc. on October 15, 2009.


Related Articles

  • Drug companies' landscape changing. Yeats, Jodi // New Zealand Doctor;9/23/2009, p33 

    The article reports on the merger and acquisition activity in the New Zealand drug industry as of September 23, 2009. Regulatory approval is being sought by Merck & Co. and Schering-Plough in countries they operate in to push the merger. Both companies have not discussed changes in operations...

  • Noted.  // Business Today;4/5/2009, Vol. 18 Issue 7, p26 

    The article presents news briefs related to business enterprises. A new advisory board and a new quality assurance and risk management head have been appointed by PricewaterhouseCoopers LLP (PwC). In a stock-and-cash transaction, there was a merger between pharmaceutical company Merck & Co. Inc....

  • Mergers scramble shape of the changing industry. Comer, Ben // Medical Marketing & Media;Apr2009, Vol. 44 Issue 4, p8 

    The article reports on the merger of companies to bring new shape to the pharmaceutical industry in the U.S. in 2009. It notes that Pfizer Inc. has announced to acquire Wyeth Inc. in January. By March, Merck & Co. Inc. announces the plan to acquire Schering-Plough Corp. for $41.1 billion....

  • Merck to close 3 sites in N.J., following high-profile merge. Daks, Martin C. // njbiz;5/3/2010, Vol. 23 Issue 18, p7 

    The article reports on the closure of three sites of Merck & Co. Inc. in New Jersey following its merger with Schering-Plough Corp. in 2009.

  • TOP 20 PHARMA: #6 MERCK.  // Contract Pharma;2009, Vol. 11 Issue 6, p62 

    The article features New Jersey-based Merck & Co. Inc. which ranked sixth in the top 20 pharmaceutical companies in 2009. According to Merck president Richard T. Clark, they acquired Schering-Plough Corp. worth 41 billion dollars in March 2009 because it will help in the growth and expansion of...

  • Manufacturing Companies.  // njbiz;7/4/2005, Vol. 18 Issue 27, p117 

    Presents a tabular representation of several manufacturing firms which are ranked according to the number of employees in New Jersey. Johnson & Johnson in New Brunswick; Merck in Whitehouse Station; Schering-Plough in Kenilworth; Pfizer in Morris Plains.

  • Mixing drugs. Galloro, Vince // Modern Healthcare;3/16/2009, Vol. 39 Issue 11, p14 

    The article reports on several deals in the pharmaceutical industry. Merck & Co. has decided to acquire Schering-Plough Corp. in a $41.1 billion deal. Under the deal, Merck shareholders will own about two-thirds of the combined company. Another deal involves Roche Holdings acquiring Genentech...

  • Big Pharma's Mid-Market Influence. Marino, Jonathan // Mergers & Acquisitions Report;5/4/2009, Vol. 22 Issue 18, p12 

    The article reports on the impact of three mergers worth a combined 156 billion U.S. dollars on the deal market in the pharmaceutical industry. Wyeth was acquired by Pfizer for 68 billion U.S. dollars, while Schering-Plough was acquired by Merck for 41.1 billion U.S. dollars. It is noted that...

  • Big Pharma's Mid-Market Influence. Marino, Jonathan // High Yield Report;5/11/2009, Vol. 20 Issue 19, p7 

    The article reports on the implications of the merger activity among large pharmaceutical companies in 2009. These deals include Pfizer's acquisition of Wyeth for 68 billion U.S. dollars, Merck's purchase of Schering-Plough for 41.1 billion U.S. dollars and Roche's win to takeover Genentech....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics